This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Hamai Y, Emi M, Ibuki Y, et al. Early recurrence and cancer death after trimodal therapy for esophageal squamous cell carcinoma. Anticancer Res. 2019;39:1433–40.
Hamai Y, Hihara J, Emi M, et al. Ability of fluorine-18 fluorodeoxyglucose positron emission tomography to predict outcomes of neoadjuvant chemoradiotherapy followed by surgical treatment for esophageal squamous cell carcinoma. Ann Thorac Surg. 2016;102:1132–9.
Hamai Y, Emi M, Ibuki Y, et al. Predictions of pathological features and recurrence based on FDG-PET findings of esophageal squamous cell carcinoma after trimodal therapy. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08609-0
Schmidt T, Lordick F, Herrmann K, Ott K. Value of functional imaging by PET in esophageal cancer. J Natl Compr Canc Netw. 2015;13:239–47.
van der Vos CS, Koopman D, Rijnsdorp S, et al. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET. Eur J Nucl Med Mol Imaging. 2017;44:4–16.
Yoichi Hamai has no conflicts of interest to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hamai, Y. ASO Author Reflections: Prediction of Pathological Features of Esophageal Cancer Using FDG-PET. Ann Surg Oncol 27, 4431–4432 (2020). https://doi.org/10.1245/s10434-020-08636-x